KD Logo

Insider Buying: RA CAPITAL MANAGEMENT, L.P., Artiva Biotherapeutics Inc [ARTV] Director invested 8,333,333 shares

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Artiva Biotherapeutics Inc shares valued at $99,999,996 were purchased by RA CAPITAL MANAGEMENT, L.P. on Jul 22 ’24. At $12.00 per share, RA CAPITAL MANAGEMENT, L.P. acquired 8,333,333 shares. The insider’s holdings grew to 8,693,579 shares worth approximately $89.2 million following the completion of this transaction.

Also, 5AM Partners VI, LLC purchased 833,333 shares, netting a total of over 9,999,996 in proceeds. Following the buying of shares at $12.00 each, the insider now holds 1,182,054 shares.

Before that, venBio Global Strategic Fund I had added 416,666 shares to its account. In a trade valued at $4,999,992, the 10% Owner bought Artiva Biotherapeutics Inc shares for $12.00 each. Upon closing the transaction, the insider’s holdings increased to 416,666 shares, worth approximately $19.87 million.

As published in their initiating research note from H.C. Wainwright on December 30, 2024, Artiva Biotherapeutics Inc [ARTV] has been a Buy and the price target has been revised to $20. Analysts at Wedbush started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid August. As of August 13, 2024, TD Cowen has initiated its “Buy” rating for ARTV. Earlier on August 13, 2024, Needham initiated its rating. Their recommendation was “a Buy” for ARTV stock.

Analyzing ARTV Stock Performance

During the last five days, there has been a surge of approximately 1.79%. Over the course of the year, Artiva Biotherapeutics Inc shares have jumped approximately 1.79%. Nevertheless, trading volume fell to 62378.0 shares from 47300.0 shares the previous day.

Support And Resistance Levels for Artiva Biotherapeutics Inc (ARTV)

According to the 24-hour chart, there is a support level at 9.66, which, if violated, would cause prices to drop to 9.05. In the upper region, resistance lies at 11.21. The next price resistance is at 12.15. RSI (Relative Strength Index) is 43.99 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.02, which suggests the price will decrease in the coming days. Percent R is at 68.98%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular